# Shared Resource 04 Cancer Proteomics

> **NIH NIH P30** · DANA-FARBER CANCER INST · 2021 · $176,049

## Abstract

Cancer Proteomics Shared Resource
Project Summary / Abstract
The Cancer Proteomics Core pushes the limits of proteomics, metabolomics, and lipidomics technologies and
specializes in cancer projects utilizing blood, urine, cerebrospinal fluid, saliva, cyst fluids, interstitial fluids, cell
and tissue extracts, as well as exosomes and single cells to: gain insight into cancer processes; discover new
biomarkers for early detection, diagnosis, prognosis, and outcome prediction; study population effects; manage
clinical trials; evaluate drug efficacy and toxicity; stratify patients; identify tumor antigens; and accelerate drug
development. A unique aspect of the Core has been its expertise in basic, translational, and clinical cancer
research, as well as in proteomics, metabolomics, lipidomics, systems biology, and bioinformatics. Unlike other
proteomics facilities, the staff is able to provide expertise in all aspects of cancer research, as well as study
design and data analysis and understands the complexities and challenges of proteomics projects.

## Key facts

- **NIH application ID:** 10062888
- **Project number:** 5P30CA006516-56
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** TOWIA A. LIBERMANN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $176,049
- **Award type:** 5
- **Project period:** 1997-03-10 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10062888

## Citation

> US National Institutes of Health, RePORTER application 10062888, Shared Resource 04 Cancer Proteomics (5P30CA006516-56). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10062888. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*